APOC3 and atherosclerosis: A similar association was seen among 2707 participants from the Framingham Heart Study: an APOC3 mutation was associated with a 46% lower plasma Apo-CIII level, and a 1 mg/dl reduction of ApoC-III level was associated with a 4% lower risk of incident ASCVD [18, 19].